Patent | Date |
---|
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Grant 11,453,655 - Abela , et al. September 27, 2 | 2022-09-27 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 11,426,407 - Miller , et al. August 30, 2 | 2022-08-30 |
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Grant 11,414,439 - Abela , et al. August 16, 2 | 2022-08-16 |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators App 20220106331 - Clemens; Jeremy J. ;   et al. | 2022-04-07 |
Methods Of Treatment For Cystic Fibrosis App 20220047564 - ALTSHULER; David M. ;   et al. | 2022-02-17 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20220041621 - Clemens; Jeremy J. ;   et al. | 2022-02-10 |
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Grant 11,066,417 - Clemens , et al. July 20, 2 | 2021-07-20 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210139514 - ABELA; Alexander Russell ;   et al. | 2021-05-13 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210052584 - Miller; Mark Thomas ;   et al. | 2021-02-25 |
Process Of Making Cftr Modulators App 20210047345 - Angell; Paul ;   et al. | 2021-02-18 |
Crystalline Forms Of Cftr Modulators App 20210047323 - Shi; Yi ;   et al. | 2021-02-18 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210047350 - Anderson; Corey Don ;   et al. | 2021-02-18 |
Modulator Of The Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator App 20210047295 - Abela; Alexander Russell ;   et al. | 2021-02-18 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator App 20210032272 - ABELA; Alexander Russell ;   et al. | 2021-02-04 |
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Grant 10,793,547 - Abela , et al. October 6, 2 | 2020-10-06 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,758,534 - Miller , et al. Sep | 2020-09-01 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20190269683 - Miller; Mark Thomas ;   et al. | 2019-09-05 |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Proces App 20190248809 - Clemens; Jeremy J. ;   et al. | 2019-08-15 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,258,624 - Miller , et al. | 2019-04-16 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20180185364 - Miller; Mark Thomas ;   et al. | 2018-07-05 |
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator App 20180162839 - Abela; Alexander Russell ;   et al. | 2018-06-14 |
Modulators of cystic fibrosis transmembrane conductance regulator Grant 9,782,408 - Miller , et al. October 10, 2 | 2017-10-10 |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20160095858 - Miller; Mark Thomas ;   et al. | 2016-04-07 |
Aryl amide sphingosine 1-phosphate analogs Grant 7,888,527 - Lynch , et al. February 15, 2 | 2011-02-15 |
Aryl Amide Sphingosine 1- App 20090137531 - Lynch; Kevin R. ;   et al. | 2009-05-28 |